Page last updated: 2024-10-26

etodolac and Allergy, Drug

etodolac has been researched along with Allergy, Drug in 3 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Research Excerpts

ExcerptRelevanceReference
"The identification of a safe and reliable alternative for patients with non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema is a frequent problem for dermatologists and other practitioners."6.73Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide. ( Chiba, Y; Ikezawa, Z; Inomata, N; Kambara, T; Onoda, M; Osuna, H; Takeshita, Y; Yamaguchi, J, 2007)
"The identification of a safe and reliable alternative for patients with non-steroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema is a frequent problem for dermatologists and other practitioners."2.73Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide. ( Chiba, Y; Ikezawa, Z; Inomata, N; Kambara, T; Onoda, M; Osuna, H; Takeshita, Y; Yamaguchi, J, 2007)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inomata, N1
Osuna, H1
Yamaguchi, J1
Onoda, M1
Takeshita, Y1
Chiba, Y1
Kambara, T1
Ikezawa, Z1
Cunha, PD1
Lord, RS1
Johnson, ST1
Wilker, PR1
Aster, RH1
Bougie, DW1
Willemin, B1
Blickle, JF1
Meaume, S1
Zerbe, S1
Brogard, JM1

Trials

1 trial available for etodolac and Allergy, Drug

ArticleYear
Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.
    The Journal of dermatology, 2007, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Asian People; Benzothi

2007

Other Studies

2 other studies available for etodolac and Allergy, Drug

ArticleYear
Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti-inflammatory drug.
    Transfusion, 2000, Volume: 40, Issue:6

    Topics: Acute Disease; Adult; Anemia, Hemolytic, Autoimmune; Animals; Anti-Inflammatory Agents, Non-Steroida

2000
[Allergic vasculitis caused by etodolac. The first case].
    Annales de medecine interne, 1989, Volume: 140, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Hypersensitivity; Etodolac; Humans; Indoleacetic Acids

1989